Coordinated by GU Ventures
NMS will be attending Swiss Nordic Bio in Zurich
Our project lead, Eduarde Rohner, will be returning to his native Switzerland to attend the Swiss Nordic Bio, in Zurich next week
◼️ He is very excited in finding ways to increase collaborations and investor interest between Swiss and Swedish Life Science innovation ecosystems.
◼️ NMS also represents its founding constellation members GU Ventures, OligoNova Hub, CCRM Nordic, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital
◼️ Don’t hesitate to reach out or pull his arm and say hi during the event!
🔶 See you there! 🔶
About New Modality Support (NMS)
NMS supports the further development and commercialization of individual research projects, primarily within the therapeutic oligonucleotide and ATMP sectors. By combining the experience and resources of participating parties with new, sector-specific expertise, value-creating services can be developed and deployed more efficiently. GU Ventures runs NMS and its partners are CCRM Nordic, OligoNova, Sahlgrenska Academy at the University of Gothenburg, and the Sahlgrenska University Hospital.
NMS is located at GoCo Health Innovation City in Mölndal and is supported by both the Västra Götaland Region through the Environment and Regional Development Board, as well as by the University of Gothenburg and GU Ventures. This support enables GU Ventures, the coordinator for NMS, to work strategically and sustainably towards the project´s success.
For more information, please visit:
